Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harte Hanks (HHS) Equity Average (2016 - 2025)

Harte Hanks (HHS) has disclosed Equity Average for 15 consecutive years, with $21.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average rose 1.11% to $21.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $21.1 million, a 1.11% increase, with the full-year FY2024 number at $20.8 million, up 7.45% from a year prior.
  • Equity Average was $21.1 million for Q3 2025 at Harte Hanks, down from $21.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $21.8 million in Q2 2025 to a low of -$53.8 million in Q1 2021.
  • A 5-year average of -$6500.0 and a median of $19.9 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: fell 26.94% in 2021, then soared 570.56% in 2023.
  • Harte Hanks' Equity Average stood at -$31.6 million in 2021, then skyrocketed by 109.54% to $3.0 million in 2022, then skyrocketed by 570.56% to $20.2 million in 2023, then increased by 5.89% to $21.4 million in 2024, then decreased by 1.45% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Equity Average are $21.1 million (Q3 2025), $21.8 million (Q2 2025), and $21.6 million (Q1 2025).